NEA Management Company’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-251,681
| Closed | -$1.23M | – | 58 |
|
|
2022
Q2 | $1.23M | Sell |
251,681
-575,342
| -70% | -$2.81M | 0.06% | 53 |
|
|
2022
Q1 | $6.22M | Sell |
827,023
-69,570
| -8% | -$523K | 0.18% | 47 |
|
|
2021
Q4 | $8.07M | Sell |
896,593
-107,700
| -11% | -$969K | 0.16% | 49 |
|
|
2021
Q3 | $16.4M | Hold |
1,004,293
| – | – | 0.19% | 44 |
|
|
2021
Q2 | $31.7M | Hold |
1,004,293
| – | – | 0.41% | 34 |
|
|
2021
Q1 | $33.9M | Hold |
1,004,293
| – | – | 0.76% | 30 |
|
|
2020
Q4 | $88.6M | Hold |
1,004,293
| – | – | 2.34% | 14 |
|
|
2020
Q3 | $81.7M | Hold |
1,004,293
| – | – | 3.46% | 11 |
|
|
2020
Q2 | $111M | Hold |
1,004,293
| – | – | 4.46% | 9 |
|
|
2020
Q1 | $64.4M | Buy |
+1,004,293
| New | +$64.4M | 3.36% | 13 |
|